Showlist patient support
Making a difference in Cancer Control
patients raviva-rekanto bis.jpg
relayfor life lux.jpg
ecl pharma recommendations.jpg
MEPS Against Cancer President
The MEPs Against Cancer work together in order to improve cancer prevention and control in Europe in the belief that European cooperation adds value to member state actions. In order to address the challenges faced by the EU, MAC will work together with the European Council, the Commission, other institutions and relevant organisations to reduce cancer incidence by 15% by the year 2020.
In the 2014 to 2019 legislature the strategic goal of the MEPs Against Cancer Group will be:
To reduce cancer incidence by promoting prevention, reduce mortality by ensuring equitable access to high quality treatment and care, and ensure a good quality of life for cancer patients and survivors.
Key areas of MAC engagement 2014 to 2019 will include (but not be limited to):
EQUALITY: Address factors such as the impact of austerity measures on healthcare services, the unequal impact of cancer on poorer individuals and households across the EU, access to medicines and the cost of medicines and treatments.
PREVENTION: strengthen cancer prevention policies in
RESEARCH: Encourage more investment in all scientific forms of cancer research and explore ways of encouraging innovation in research.
REGISTRATION: Support the extension and improvement of population based registries in all member states. National Cancer Control Plans should be based on cancer registries data.
PROTECTION: Protect the data of individuals that are given and used for health research.
PATIENTS: Ensure meaningful inclusion of the patient voice within every cancer action.
QUALITY: Reinforce initiatives to improve quality of cancer care such as the creation of European reference centres for cancer treatments.
RARE CANCERS: Ensure political attention to rare cancers within the framework of the priorities of the Rare Cancer Europe network.
MEP Michele Rivasi, MEP Nessa Childers and MEP Dagmar Roth-Behrendt are all currently MAC vice-Presidents